ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPK-01128
製品名称
LRG1 Protein, Mouse, Recombinant (His)
タンパク質名
LRG1
Species
Mouse
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms Leucine-rich α-2-glycoprotein, Leucine-rich alpha-2-glycoprotein, LRG1, LRG
Characteristics Activity has not been tested. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Endotoxin Level < 1 EU/μg by the LAL method.
Purity > 95%
Description Diabetic nephropathy (DN) is an important public health concern of increasing proportions and the leading cause of end-stage renal disease (ESRD) in diabetic patients. It is one of the most common long-term microvascular complications of diabetes mellitus that is characterized by proteinuria and glomerular structural changes. LRG1 is a novel pro-angiogenic factors involved in the abnormal angiogenesis and renal fibrosis in DN. LRG1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 34.9 kDa and the accession number is Q91XL1.
Reference Zhang A, et al. Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy. Front Physiol. 2020 Aug 31;11:1064. doi: 10.3389/fphys.2020.01064. PMID: 32982792; PMCID: PMC7488177.
URL https://www.targetmol.com/recombinant-protein/lrg1_protein_mouse_recombinant_his_

お問い合わせリスト(-)

お問い合わせフォーム